Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07499037 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
The standard and most common therapy is anticoagulation with heparin according to activated partial thromboplastin time (aPTT) during extracorporeal membrane oxygenation (ECMO) support. The study will focus on evaluating the efficacy and safety of new anticoagulants on ECMO, namely argatroban and enoxaparin in lower doses controlled according to targeted antiIIa and antiXa markers.
Trial Details
NCT Number NCT07499037
Lead Sponsor University Hospital Ostrava
Collaborators: University Hospital, Motol
Conditions
(from sponsor)		 Pneumonia, Heart Failure
Related terms Heart Failure, Pneumonia
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov